Edap Tms (NASDAQ:EDAP) Shares Cross Above Two Hundred Day Moving Average – Here’s Why

Edap Tms S.A. (NASDAQ:EDAP)’s share price passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $2.49 and traded as high as $4.20. Edap Tms shares last traded at $4.00, with a volume of 35,373 shares.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on EDAP. Weiss Ratings reissued a “sell (d-)” rating on shares of Edap Tms in a research note on Monday, December 29th. Wall Street Zen upgraded Edap Tms to a “hold” rating in a report on Saturday. Finally, Jefferies Financial Group reissued a “hold” rating and issued a $2.00 price objective on shares of Edap Tms in a research note on Thursday, November 6th. One analyst has rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $8.50.

Edap Tms Price Performance

The company has a market capitalization of $176.85 million, a PE ratio of -8.30 and a beta of -0.16. The company has a debt-to-equity ratio of 0.04, a quick ratio of 0.97 and a current ratio of 1.41. The stock has a 50 day moving average price of $3.41 and a two-hundred day moving average price of $2.52.

Edap Tms (NASDAQ:EDAP) last announced its quarterly earnings results on Thursday, November 6th. The medical equipment provider reported ($0.15) EPS for the quarter, beating the consensus estimate of ($0.26) by $0.11. The business had revenue of $16.29 million during the quarter, compared to analysts’ expectations of $15.05 million. Edap Tms had a negative return on equity of 61.60% and a negative net margin of 30.95%. Equities analysts forecast that Edap Tms S.A. will post -0.6 earnings per share for the current year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the business. Financial Planning Navigators CORP acquired a new stake in shares of Edap Tms in the 4th quarter valued at $33,000. Sage Mountain Advisors LLC bought a new position in Edap Tms during the second quarter valued at about $165,000. Finally, Leonteq Securities AG acquired a new stake in shares of Edap Tms in the fourth quarter worth about $313,000. Institutional investors own 62.74% of the company’s stock.

Edap Tms Company Profile

Edap Tms SA (NASDAQ: EDAP) is a Lyon, France–based medical device company that develops and markets noninvasive therapeutic systems for urological applications. The firm’s core focus lies in high-intensity focused ultrasound (HIFU) for localized prostate tissue ablation and extracorporeal shock-wave lithotripsy for kidney stone fragmentation. Edap Tms’s Ablatherm HIFU platform delivers targeted ultrasound energy to treat prostate cancer without incisions, while its Sonolith line offers pulse-focused shock waves designed to break down urinary calculi.

Since its founding in 1989, Edap Tms has pursued regulatory clearances in multiple markets, including CE marking in Europe and FDA clearance for its HIFU system in the United States.